1.7 million Americans are impacted by sepsis each year—and early detection can mean the difference between life and death.
That’s why in February 2025 we announced our investment in Vail Scientific, LLC, a company aiming to redefine how we detect and respond to sepsis. Their vSNO™ Sepsis Screening Device, developed in partnership with Minnetronix Medical, is a major step toward faster, noninvasive sepsis detection—something that could transform patient outcomes.
➡️ Curious about how this game-changing tech is coming to life? Check out the full story here: https://lnkd.in/gXAJ5iu9
